Solid phase is very sensitive to warm autos, though I wouldn't call those 'false' positives - they are more a pain in the tush. Repeat the screen with PeG or LISS. If the repeat screen doesn't react, do an AHG crossmatch with that enhancement - good to go.
Solid phase on occasion will pick up a non-specific reacting antibody. Run a panel (or 2) and rule out all common clinically significant alloantibodies, do an AHG crossmatch with solid phase - good to go. There are facilities who've done retrospective studies which seem to be showing that up to 30% of these types of patients at some facilities (this would depend on the patient population) are in the process of making an antibody that will be identifiable at a future visit. We've seen a couple of patients that seem to fit in that category. Another thought for these reactions is that the patient is actually demonstrating an antibody to a crypt antigen on the screen/panel cell. The crypt antigen is exposed because of the way the antibody screen and panel cells are prepared for microwell testing.
Personally, I was vaguely dissatisfied with gel. When we were using gel, there were too many patients that we had to perform tube/PeG antibody IDs on to identify weakly reactive antibodies. We could tell there was something there in gel, but there weren't enough/strong enough reactions to ID. With solid phase, some of these same patients were reacting 2+ or better.
I'm willing to trade a few annoying 'false' positives for the increased sensitivity of solid phase. My 'no interpertation' rate is usually under 2% of our antibody screens. We do about 400 ABS a month, so that's anywhere from 8 -12 questionable patient results on average, some months can be few more. But again, consider your patient population. I see a lot of patients with no history and frequently transfused patients, percentage wise, in our patient population. The increase in sensitivity is a good thing for us.